Adding high-dose radiation to standard treatment for advanced lung cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether adding a high, focused dose of radiation to the usual first treatment (chemo and/or immunotherapy) can help people with non-small cell lung cancer that has spread to a limited number of spots (up to 5). The goal is to see if this approach improves how well the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of non-small cell lung cancer (NSCLC).
- Your cancer has spread to 5 or fewer spots outside the original tumor (not counting the main tumor or nearby lymph nodes).
- You are well enough to receive standard first treatment with chemo and/or immunotherapy.
- The cancer spots outside the chest must be reachable for a special type of focused radiation (SBRT).
- You have not had any prior systemic treatment (like chemo) or radiation for this lung cancer.
- You are 18 years or older and have a good performance status (able to do daily activities with little or no help).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving high-precision radiation to a few spots that are growing during immunotherapy (with or without chemotherapy) can help people with advanced lung cancer. It aims to see if treating these limited areas of resistance can extend the time the cancer stays under control.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This study tests whether adding focused radiation therapy to immunotherapy can help patients with advanced non-small cell lung cancer whose cancer has progressed despite prior immunotherapy. The goal is to see if this combination works better than immunotherapy alone.
This trial is testing whether giving focused radiation therapy to the main lung tumor, in addition to standard treatments like targeted therapy or chemo-immunotherapy, can help people with advanced lung cancer that has spread to many places. The goal is to see if adding this radiation can improve outcomes without causing too many side effects.
This trial tests whether adding high-dose, targeted radiation to the usual treatment helps people with locally advanced, non-operable lung cancer live longer or better control the cancer. It may help shrink tumors in the chest and improve outcomes when surgery can’t be done.
This trial tests whether giving radiotherapy to the main lung tumor, along with the usual medicines (like chemotherapy or immunotherapy), can help people with stage IV lung cancer. The goal is to see if adding this treatment helps control the cancer and improves how long patients live.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.